ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Isotretinoin-Mepha Weichkapseln:Mepha Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
D10BA01 - IsotretinoinATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D10 - Anti-Acne Preparations
 

The DDDs are based on the treatment of severe acne.

D10B - Anti-Acne Preparations for Systemic Use

This group comprises drugs for systemic use in the treatment of acne. Antibiotics, such as tetracyclines and erythromycin, which are also used for the treatment of acne, are classified in group J.
Combinations of e.g. estrogen and antiandrogen, used for the treatment of acne, are classified in group G03 - Sex hormones and modulators of the genital system.

D10BA - Retinoids for Treatment Of Acne

Retinoids used in severe psoriasis are classified in D05BB, whereas alitretinoin used for hand eczema is classified in D11A.

D10BA01 - Isotretinoin
DoseRoute of administrationNote
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home